Rising Liver Cancer Mortality in Europe Linked to Hepatitis B and C Infections Amidst Variance in Prevention and Treatment Primary liver cancer is the sixth most common cause of cancer-related deaths in Europe. Infection with hepatitis B or C is one of the main risk […]

DiCE’s Report from the AMMF Annual Cholangiocarcinoma Conference The Alan Moremont Memorial Fund (AMMF) is the UK’s Cholangiocarcinoma charity. Its annual conference brings together UK and international experts w […]

Early-Age Onset Digestive Cancers – a Global Review of this Worrisome Trend The term ‘early-onset digestive cancers’ refers to digestive cancers arising in people under the age of 50. When it comes to digestive cancers, what […]

Fruquintinib: A New Medicine for mCRC Recommended for Approval in Europe A new medicine for metastatic colorectal cancer (mCRC) has been recommended for approval by the European Medicines Agency (EMA). Called […]

Extending Colonoscopy Screening Intervals: A New Approach to Colorectal Cancer Prevention Having a colonoscopy is the best way to check and screen for colorectal cancer (CRC). A small camera on a bendy tube is passed through the anus and […]

DiCE’s Report from the EASL Liver Cancer Summit The EASL | The Home of Hepatology Liver Cancer Summit took place in Rotterdam, The Netherlands, from 22 – 24 February. This annual meeting is […]

Biomarkers and their Role in the Diagnosis and Treatment of Cholangiocarcinoma (CCA) What is CCA? Cholangiocarcinoma (CCA) is a cancer that starts in the biliary tract. The biliary tract includes the liver, gallbladder and bile […]